A Trial to Learn What Happens to Different Medicinal Forms of BAY2328065 When They Enter the Body and How Safe They Are in Healthy Male and Female Participants
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Endometriosis
- Type
- Interventional
- Phase
- Phase 1
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentIntervention Model Description: Study Groups 1 and 2 using a fixed sequence parallel group design Study Group 3 using a fixed sequence design Study Group 4 using a placebo-controlled parallel design Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)Masking Description: Study Groups 1 and 2: open-label Study Group 3: open-label Study Group 4: double-blind Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 55 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04851483
- Collaborators
- Not Provided
- Investigators
- Not Provided